Pfizer (PFE) Lacks Earnings Momentum According to Analyst Jim Cramer
Published on 5/14/2026

AI Summary
Analyst Jim Cramer stated that Pfizer (PFE) does not have any current earnings momentum. This observation could indicate potential concerns regarding PFE’s future stock performance in the market. Without positive earnings momentum, investor confidence may decline, potentially affecting the stock's valuation. It is essential for investors to monitor PFE's earnings reports closely to gauge any changes in momentum.
Related News

Earnings
Tesla (TSLA) Reports Q2 Deliveries: Expected 406k Vehicles
Jun 28

Earnings
Vanguard Total Stock Market ETF (VTI) Averages 10% Annual Returns
Jun 28

Tech
Micron (MU) Revenue Surpasses $41 Billion Amid AI Demand Surge
Jun 28

Earnings
GameStop (GME) Reports $7.4 Billion Cash Amid Transformation Efforts
Jun 28